CNTX
Context Therapeutics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
Context Therapeutics has 6 disclosed suppliers and 0 disclosed customers in SEC filings.
SentenceOn September 23, 2024, we entered into a license agreement (the "BioAtla License Agreement") with BioAtla, Inc. ("BioAtla"), pursuant to which we obtained an exclusive, worldwide license to develop, manufacture and commercialize two licensed antibodies (the "BioAtla Assets"), including BA3362 (renamed by the Company as CT-202), BioAtla's Nectin-4 x CD3 TCE.
CNTX 10-Kaccession 0001628280-26-020498
SentenceIn April 2021, we entered into a collaboration and licensing agreement with Integral Molecular, Inc. ("Integral") (the "Integral License Agreement") for the development of a CLDN6 bsAb for cancer therapy.
CNTX 10-Kaccession 0001628280-26-020498
SentenceTo date, we have obtained active pharmaceutical ingredients ("API") and drug product for our product candidates from several third-party contract manufacturers, including Lonza Sales AG ("Lonza Sales") and Lonza AG ("Lonza AG", and collectively with Lonza Sales, "Lonza") and Just-Evotec Biologics, Inc.
CNTX 10-Kaccession 0001628280-26-020498
SentenceIn consideration of the Transferred Assets, we made a one-time payment to Link of $3.75 million.
CNTX 10-Kaccession 0001628280-26-020498
SentenceTo date, we have obtained active pharmaceutical ingredients ("API") and drug product for our product candidates from several third-party contract manufacturers, including Lonza Sales AG ("Lonza Sales") and Lonza AG ("Lonza AG", and collectively with Lonza Sales, "Lonza") and Just-Evotec Biologics, Inc.
CNTX 10-Kaccession 0001628280-26-020498
SentenceTo date, we have obtained active pharmaceutical ingredients ("API") and drug product for our product candidates from several third-party contract manufacturers, including Lonza Sales AG ("Lonza Sales") and Lonza AG ("Lonza AG", and collectively with Lonza Sales, "Lonza") and Just-Evotec Biologics, Inc.
CNTX 10-Kaccession 0001628280-26-020498
—
—
Context Therapeutics Inc.
0.19
Largest filed tie
—
Expected move
No implied move.